(Q36610962)

15 August 2017

Clinical pharmacodynamic factors in docetaxel toxicity (English)

1 reference

15 August 2017

1 reference

1 reference

F Puisset

1

1 reference

15 August 2017

J Alexandre

2

1 reference

15 August 2017

J-M Treluyer

3

1 reference

15 August 2017

V Raoul

4

1 reference

15 August 2017

H Roché

5

1 reference

15 August 2017

F Goldwasser

6

1 reference

15 August 2017

E Chatelut

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

26 June 2007

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

97

1 reference

15 August 2017

3

1 reference

15 August 2017

290-296

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603872

15 August 2017

0 references

cites work

Clinical pharmacokinetics of docetaxel : recent developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Relationship of systemic exposure to unbound docetaxel and neutropenia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Estimating population kinetics.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

A population pharmacokinetic model for docetaxel (Taxotere): model building and validation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients?

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Dexamethasone as a probe for docetaxel clearance.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Model of chemotherapy-induced myelosuppression with parameter consistency across drugs

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360335

Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17595656

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6603872

1 reference

15 August 2017

1 reference

15 August 2017

1 reference